Ion forced to split Broadway, keeping FX

Remedy satisfies UK competition watchdog – but “a big defeat” for acquisitive tech giant

circuit-board-split
Risk.net montage

Trading systems giant Ion will split up Broadway Technology – the rival it acquired in February – to allay concerns the deal would erode competition in the market for fixed income trading software.

An initial review by the UK’s Competition and Markets Authority concluded on July 7 that a months-long probe was warranted. In a further report, published today, the CMA revealed Ion’s proposed remedy – an undertaking to keep only Broadway’s foreign exchange business and find a buyer for the firm’s

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services - www.fx-markets.com/static/contact-us, or view our subscription options here: https://subscriptions.fx-markets.com/subscribe

You are currently unable to copy this content. Please contact info@fx-markets.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

FX automation: mission incomplete?

This FX Markets webinar delves into the evolution of FX trading desks, the challenges to automating trade workflows, and what vendors and liquidity providers are doing to address this

Most read articles loading...

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: